Dextera Surgical Stock Price, News & Analysis (NASDAQ:DXTR)

$0.06 -0.01 (-14.29 %)
(As of 12/15/2017 01:12 AM ET)
Previous Close$0.06
Today's Range$0.06 - $0.07
52-Week Range$0.05 - $2.33
Volume3.26 million shs
Average Volume2.23 million shs
Market Capitalization$4.29 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.38

About Dextera Surgical (NASDAQ:DXTR)

Dextera Surgical logoDextera Surgical Inc., formerly Cardica, Inc., designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons. Its MicroCutter 5/80 is a commercially available cartridge-based microcutter device with approximately five millimeter shaft diameter, over 80 degrees of articulation, and an approximately 30 millimeter staple line cleared for specified indications for use in the United States, and in the European Union (EU) for a range of indications for use. It designs, manufactures and markets automated anastomotic systems used by surgeons to perform anastomoses during on- or off-pump coronary artery bypass graft procedures and these products include the C-Port xA system, the C-Port Flex A system and the PAS-Port Proximal Anastomosis System.

Receive DXTR News and Ratings via Email

Sign-up to receive the latest news and ratings for DXTR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:DXTR
CUSIPN/A
Phone650-364-9975

Debt

Debt-to-Equity RatioN/A
Current Ratio0.47%
Quick Ratio0.37%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$3.42 million
Price / Sales0.85
Cash FlowN/A
Price / CashN/A
Book Value($0.21) per share
Price / Book-0.29

Profitability

Trailing EPS($1.40)
Net Income$-17,220,000.00
Net Margins-402.96%
Return on EquityN/A
Return on Assets-195.83%

Miscellaneous

Employees50
Outstanding Shares48,210,000

Dextera Surgical (NASDAQ:DXTR) Frequently Asked Questions

What is Dextera Surgical's stock symbol?

Dextera Surgical trades on the NASDAQ under the ticker symbol "DXTR."

How were Dextera Surgical's earnings last quarter?

Dextera Surgical Inc (NASDAQ:DXTR) announced its quarterly earnings results on Thursday, November, 9th. The medical instruments supplier reported ($0.09) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.07) by $0.02. The medical instruments supplier earned $0.69 million during the quarter, compared to analyst estimates of $0.62 million. View Dextera Surgical's Earnings History.

When will Dextera Surgical make its next earnings announcement?

Dextera Surgical is scheduled to release their next quarterly earnings announcement on Tuesday, February, 6th 2018. View Earnings Estimates for Dextera Surgical.

Where is Dextera Surgical's stock going? Where will Dextera Surgical's stock price be in 2017?

2 equities research analysts have issued 12-month price objectives for Dextera Surgical's stock. Their predictions range from $0.70 to $0.80. On average, they expect Dextera Surgical's stock price to reach $0.75 in the next year. View Analyst Ratings for Dextera Surgical.

Who are some of Dextera Surgical's key competitors?

Who are Dextera Surgical's key executives?

Dextera Surgical's management team includes the folowing people:

  • Julian N Nikolchev, President, Chief Executive Officer, Director (Age 61)
  • Robert Y. Newell IV, Chief Financial Officer, Vice President - Finance (Age 67)
  • Thomas J. Palermo, Chief Operating Officer (Age 53)
  • Liam J. Burns, Vice President - Sales and Marketing (Age 50)
  • Gregory P. Watson, Vice President of operation (Age 60)
  • Michael A. Bates, Director (Age 57)
  • Gregory D. Casciaro, Director (Age 57)
  • Robert Michael Kleine, Director (Age 63)
  • Samuel E. Navarro, Director (Age 59)

How do I buy Dextera Surgical stock?

Shares of Dextera Surgical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Dextera Surgical's stock price today?

One share of Dextera Surgical stock can currently be purchased for approximately $0.06.

How big of a company is Dextera Surgical?

Dextera Surgical has a market capitalization of $4.29 million and generates $3.42 million in revenue each year. The medical instruments supplier earns $-17,220,000.00 in net income (profit) each year or ($1.40) on an earnings per share basis. Dextera Surgical employs 50 workers across the globe.

How can I contact Dextera Surgical?

Dextera Surgical's mailing address is 900 SAGINAW DRIVE, REDWOOD CITY CA, 94063. The medical instruments supplier can be reached via phone at 650-364-9975 or via email at [email protected]


MarketBeat Community Rating for Dextera Surgical (DXTR)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  109 (Vote Outperform)
Underperform Votes:  109 (Vote Underperform)
Total Votes:  218
MarketBeat's community ratings are surveys of what our community members think about Dextera Surgical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Dextera Surgical (NASDAQ:DXTR) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $0.75$0.75$0.75$3.50
Price Target Upside: 200.00% upside200.00% upside200.00% upside161.19% upside

Dextera Surgical (NASDAQ:DXTR) Consensus Price Target History

Price Target History for Dextera Surgical (NASDAQ:DXTR)

Dextera Surgical (NASDAQ:DXTR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/16/2017Ladenburg Thalmann Financial ServicesInitiated CoverageBuy -> Buy$0.80HighView Rating Details
7/12/2017WedbushLower Price TargetOutperform$3.50 -> $0.70HighView Rating Details
(Data available from 12/15/2015 forward)

Earnings

Dextera Surgical (NASDAQ:DXTR) Earnings History and Estimates Chart

Earnings by Quarter for Dextera Surgical (NASDAQ:DXTR)

Dextera Surgical (NASDAQ DXTR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/6/2018        
11/9/2017Q1 2018($0.07)($0.09)$0.62 million$0.69 millionViewN/AView Earnings Details
8/8/2017Q4 2017($0.11)($0.40)$1.03 million$1.05 millionViewListenView Earnings Details
5/4/2017Q3 2017($0.48)($0.50)$1.10 million$1.11 millionViewListenView Earnings Details
2/7/2017Q217($0.34)($0.41)$0.67 million$0.80 millionViewListenView Earnings Details
11/7/2016Q1($0.48)($0.44)$0.61 million$0.47 millionViewListenView Earnings Details
8/9/2016Q4($0.47)($0.48)$0.62 million$0.72 millionViewListenView Earnings Details
2/4/2016Q2($0.05)($0.05)$0.73 million$0.70 millionViewListenView Earnings Details
11/5/2015Q116($0.05)($0.05)$0.71 million$0.76 millionViewListenView Earnings Details
8/6/2015Q415($0.05)($0.04)$0.50 million$0.70 millionViewListenView Earnings Details
5/6/2015Q315($0.05)($0.05)$0.54 million$0.56 millionViewListenView Earnings Details
2/5/2015Q215($0.05)($0.06)$0.97 million$0.66 millionViewListenView Earnings Details
11/4/2014Q1($0.06)($0.06)$1.18 million$1.07 millionViewListenView Earnings Details
8/7/2014Q4($0.06)($0.08)$0.93 million$1.03 millionViewListenView Earnings Details
2/4/2014Q2($0.08)($0.11)ViewListenView Earnings Details
11/4/2013Q1 14($0.07)($0.07)ViewN/AView Earnings Details
11/5/2012Q113($0.10)($0.11)$1.05 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Dextera Surgical (NASDAQ:DXTR) Earnings Estimates

2017 EPS Consensus Estimate: ($1.31)
2018 EPS Consensus Estimate: ($0.20)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.49)($0.49)($0.49)
Q2 20171($0.23)($0.23)($0.23)
Q3 20171($0.49)($0.49)($0.49)
Q4 20171($0.10)($0.10)($0.10)
Q1 20181($0.05)($0.05)($0.05)
Q2 20181($0.05)($0.05)($0.05)
Q3 20181($0.05)($0.05)($0.05)
Q4 20181($0.05)($0.05)($0.05)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Dextera Surgical (NASDAQ:DXTR)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Dextera Surgical (NASDAQ DXTR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 10.43%
Institutional Ownership Percentage: 4.49%
Insider Trades by Quarter for Dextera Surgical (NASDAQ:DXTR)
Institutional Ownership by Quarter for Dextera Surgical (NASDAQ:DXTR)

Dextera Surgical (NASDAQ DXTR) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/16/2016Thomas J PalermoCOOBuy6,300$2.62$16,506.00View SEC Filing  
2/29/2016Michael A BatesDirectorBuy35,400$3.53$124,962.00View SEC Filing  
2/26/2016Thomas J PalermoCOOBuy7,500$3.77$28,275.00View SEC Filing  
2/24/2016Michael A BatesDirectorBuy26,600$2.99$79,534.00View SEC Filing  
2/23/2016Julian NikolchevInsiderBuy1,146$2.60$2,979.60View SEC Filing  
2/23/2016Michael A BatesDirectorBuy5,000$2.63$13,150.00View SEC Filing  
2/22/2016Julian NikolchevInsiderBuy2,696$2.60$7,009.60View SEC Filing  
2/22/2016Michael A BatesDirectorBuy2,000$2.62$5,240.00View SEC Filing  
2/19/2016Michael A BatesDirectorBuy1,000$2.53$2,530.00View SEC Filing  
2/12/2016Robert Y. Iv NewellCFOBuy40,000$0.26$10,400.00View SEC Filing  
2/11/2016Julian NikolchevInsiderBuy37,680$0.27$10,173.60View SEC Filing  
2/9/2016Gregory P WatsonVPBuy75,000$0.25$18,750.00View SEC Filing  
11/24/2014Gary S PetersmeyerDirectorBuy25,000$0.60$15,000.00View SEC Filing  
11/24/2014Robert Y Iv NewellCFOBuy20,000$0.60$12,000.00View SEC Filing  
11/13/2014Robert Y Iv NewellCFOBuy10,000$0.87$8,700.00View SEC Filing  
11/10/2014William H Younger JrDirectorBuy34,354$0.91$31,262.14View SEC Filing  
5/23/2014Jeffrey PurvinDirectorBuy5,000$0.95$4,750.00View SEC Filing  
5/22/2014Robert Y Iv NewellCFOBuy10,000$0.95$9,500.00View SEC Filing  
11/21/2013Bernard A HausenCEOBuy5,500$0.95$5,225.00View SEC Filing  
11/18/2013Robert Y Iv NewellCFOBuy10,000$0.95$9,500.00View SEC Filing  
3/20/2013Hill Ventures SutterMajor ShareholderBuy981,736$1.05$1,030,822.80View SEC Filing  
3/20/2013Robert Y Iv NewellCFOBuy8,000$1.05$8,400.00View SEC Filing  
3/20/2013William H Younger JrDirectorBuy1,244,678$1.05$1,306,911.90View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Dextera Surgical (NASDAQ DXTR) News Headlines

Source:
DateHeadline
Dextera Surgical (DXTR) Files for Chapter 11 BankruptcyDextera Surgical (DXTR) Files for Chapter 11 Bankruptcy
www.streetinsider.com - December 13 at 9:35 AM
Dextera Surgical (DXTR) Rating Increased to Hold at Zacks Investment ResearchDextera Surgical (DXTR) Rating Increased to Hold at Zacks Investment Research
www.americanbankingnews.com - December 12 at 9:28 PM
Dextera Surgical Files For Bankruptcy - Quick FactsDextera Surgical Files For Bankruptcy - Quick Facts
www.nasdaq.com - December 12 at 5:57 PM
[$$] Dextera Surgical Files for Bankruptcy With $17.3 Million Buyout Offer From Aesculap[$$] Dextera Surgical Files for Bankruptcy With $17.3 Million Buyout Offer From Aesculap
finance.yahoo.com - December 12 at 5:57 PM
Dextera Surgical (DXTR) Files for Chapter 11 Bankruptcy - StreetInsider.comDextera Surgical (DXTR) Files for Chapter 11 Bankruptcy - StreetInsider.com
www.streetinsider.com - December 12 at 9:48 AM
Zacks: Analysts Anticipate Dextera Surgical Inc (DXTR) to Announce -$0.06 EPSZacks: Analysts Anticipate Dextera Surgical Inc (DXTR) to Announce -$0.06 EPS
www.americanbankingnews.com - December 7 at 3:36 PM
Reviewing Dextera Surgical (DXTR) & Thoratec (THOR)Reviewing Dextera Surgical (DXTR) & Thoratec (THOR)
www.americanbankingnews.com - December 3 at 11:40 PM
Breakfast Technical Briefing on Medical Supplies Stocks -- Endologix, Dextera Surgical, Becton, Dickinson, and Ekso BionicsBreakfast Technical Briefing on Medical Supplies Stocks -- Endologix, Dextera Surgical, Becton, Dickinson, and Ekso Bionics
www.bizjournals.com - November 21 at 6:17 PM
$880,000.00 in Sales Expected for Dextera Surgical Inc. (DXTR) This Quarter$880,000.00 in Sales Expected for Dextera Surgical Inc. (DXTR) This Quarter
www.americanbankingnews.com - November 21 at 6:46 AM
-$0.06 EPS Expected for Dextera Surgical Inc. (DXTR) This Quarter-$0.06 EPS Expected for Dextera Surgical Inc. (DXTR) This Quarter
www.americanbankingnews.com - November 19 at 7:12 PM
Dextera Surgical Inc. (DXTR) Sees Significant Decrease in Short InterestDextera Surgical Inc. (DXTR) Sees Significant Decrease in Short Interest
www.americanbankingnews.com - November 12 at 1:32 AM
Dextera Surgical Inc. (DXTR) Releases  Earnings Results, Misses Expectations By $0.02 EPSDextera Surgical Inc. (DXTR) Releases Earnings Results, Misses Expectations By $0.02 EPS
www.americanbankingnews.com - November 10 at 7:32 PM
Dextera Surgical, Inc. to Host Earnings CallDextera Surgical, Inc. to Host Earnings Call
finance.yahoo.com - November 10 at 11:34 AM
Dextera Surgical Reports Fiscal 2018 First Quarter Financial ResultsDextera Surgical Reports Fiscal 2018 First Quarter Financial Results
finance.yahoo.com - November 10 at 11:34 AM
Dextera Surgical to Cancel Fiscal 2018 First Quarter Financial Results Conference Call on Thursday November 9, 2017Dextera Surgical to Cancel Fiscal 2018 First Quarter Financial Results Conference Call on Thursday November 9, 2017
finance.yahoo.com - November 9 at 1:22 AM
Why Dextera Surgical Inc’s (DXTR) Investor Composition Impacts Your ReturnsWhy Dextera Surgical Inc’s (DXTR) Investor Composition Impacts Your Returns
finance.yahoo.com - November 3 at 6:29 PM
Zacks: Brokerages Anticipate Dextera Surgical Inc. (DXTR) Will Announce Quarterly Sales of $620,000.00Zacks: Brokerages Anticipate Dextera Surgical Inc. (DXTR) Will Announce Quarterly Sales of $620,000.00
www.americanbankingnews.com - November 1 at 2:32 PM
Dextera Surgical to Announce Fiscal 2018 First Quarter Financial Results on Thursday November 9, 2017Dextera Surgical to Announce Fiscal 2018 First Quarter Financial Results on Thursday November 9, 2017
finance.yahoo.com - October 30 at 6:47 PM
Dextera Surgical Inc. (DXTR) to Release Quarterly Earnings on MondayDextera Surgical Inc. (DXTR) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - October 30 at 9:14 AM
MedTech Growing on Emerging Markets, M&A: Stocks to BuyMedTech Growing on Emerging Markets, M&A: Stocks to Buy
finance.yahoo.com - October 25 at 7:47 PM
Tech Stocks to Keep on Your RadarTech Stocks to Keep on Your Radar
finance.yahoo.com - October 20 at 7:35 PM
Dextera Surgical (DXTR) & Its Peers Critical AnalysisDextera Surgical (DXTR) & Its Peers Critical Analysis
www.americanbankingnews.com - October 17 at 10:36 AM
Dextera Surgical Inc. (DXTR) Expected to Post Quarterly Sales of $620,000.00Dextera Surgical Inc. (DXTR) Expected to Post Quarterly Sales of $620,000.00
www.americanbankingnews.com - October 13 at 1:48 PM
Brokers Set Expectations for Dextera Surgical Inc.s FY2018 Earnings (DXTR)Brokers Set Expectations for Dextera Surgical Inc.'s FY2018 Earnings (DXTR)
www.americanbankingnews.com - October 12 at 1:54 PM
Zacks: Analysts Anticipate Dextera Surgical Inc. (DXTR) Will Announce Earnings of -$0.06 Per ShareZacks: Analysts Anticipate Dextera Surgical Inc. (DXTR) Will Announce Earnings of -$0.06 Per Share
www.americanbankingnews.com - October 11 at 4:30 AM
Dextera Surgical Inc. (DXTR) Upgraded to "Hold" by Zacks Investment ResearchDextera Surgical Inc. (DXTR) Upgraded to "Hold" by Zacks Investment Research
www.americanbankingnews.com - October 11 at 12:04 AM
Dextera Surgical (DXTR) Says MicroCutter 5/80 and Cardiac Anastomotic Devices to Be Featured at EACTSDextera Surgical (DXTR) Says MicroCutter 5/80 and Cardiac Anastomotic Devices to Be Featured at EACTS
www.streetinsider.com - October 10 at 6:14 AM
Reviewing Dextera Surgical (DXTR) & Varian Medical Systems (VAR)Reviewing Dextera Surgical (DXTR) & Varian Medical Systems (VAR)
www.americanbankingnews.com - October 10 at 4:28 AM
Dextera Surgical (DXTR) Says MicroCutter 5/80 and Cardiac Anastomotic Devices to Be Featured at EACTS - StreetInsider.comDextera Surgical (DXTR) Says MicroCutter 5/80 and Cardiac Anastomotic Devices to Be Featured at EACTS - StreetInsider.com
www.streetinsider.com - October 9 at 6:27 PM
Dextera Surgical’s MicroCutter 5/80™ and Cardiac Anastomotic Devices to Be Featured at the 31st Annual European Association for Cardio-Thoracic SurgeryDextera Surgical’s MicroCutter 5/80™ and Cardiac Anastomotic Devices to Be Featured at the 31st Annual European Association for Cardio-Thoracic Surgery
finance.yahoo.com - October 9 at 6:27 PM
Dextera Surgical (DXTR) Says it Working to Resolve Issues; Plans to Explore All Strategic Options - StreetInsider.comDextera Surgical (DXTR) Says it Working to Resolve Issues; Plans to Explore All Strategic Options - StreetInsider.com
www.streetinsider.com - October 7 at 3:42 PM
Edited Transcript of DXTR earnings conference call or presentation 5-Oct-17 12:30pm GMTEdited Transcript of DXTR earnings conference call or presentation 5-Oct-17 12:30pm GMT
finance.yahoo.com - October 5 at 10:18 PM
Dextera Surgical Inc. (DXTR) Sees Large Increase in Short InterestDextera Surgical Inc. (DXTR) Sees Large Increase in Short Interest
www.americanbankingnews.com - September 30 at 3:26 AM
Dextera Surgical Hosts Hands-on Training Course for Video-Assisted Thoracic Surgery Techniques Using MicroCutter ... - Business Wire (press release)Dextera Surgical Hosts Hands-on Training Course for Video-Assisted Thoracic Surgery Techniques Using MicroCutter ... - Business Wire (press release)
www.businesswire.com - September 28 at 9:04 AM
Dextera Surgical Hosts Hands-on Training Course for Video-Assisted Thoracic Surgery Techniques Using MicroCutter 5/80™ for SegmentectomyDextera Surgical Hosts Hands-on Training Course for Video-Assisted Thoracic Surgery Techniques Using MicroCutter 5/80™ for Segmentectomy
www.nasdaq.com - September 28 at 12:09 AM
Dextera Surgical (DXTR) Presents At Ladenburg Thalmann 2017 Healthcare Conference - SlideshowDextera Surgical (DXTR) Presents At Ladenburg Thalmann 2017 Healthcare Conference - Slideshow
seekingalpha.com - September 27 at 7:08 PM
Dextera Surgical (DXTR) vs. Its Competitors Critical ReviewDextera Surgical (DXTR) vs. Its Competitors Critical Review
www.americanbankingnews.com - September 21 at 12:32 PM
Head to Head Survey: Dextera Surgical (DXTR) vs. GenMark Diagnostics (GNMK)Head to Head Survey: Dextera Surgical (DXTR) vs. GenMark Diagnostics (GNMK)
www.americanbankingnews.com - September 11 at 10:40 AM
$1.02 Million in Sales Expected for Dextera Surgical Inc. (DXTR) This Quarter$1.02 Million in Sales Expected for Dextera Surgical Inc. (DXTR) This Quarter
www.americanbankingnews.com - September 5 at 3:48 AM
 Analysts Expect Dextera Surgical Inc. (DXTR) Will Announce Earnings of -$0.06 Per Share Analysts Expect Dextera Surgical Inc. (DXTR) Will Announce Earnings of -$0.06 Per Share
www.americanbankingnews.com - September 3 at 8:28 PM
Dextera Surgical Receives Expanded Indication in Solid Organ Surgery for MicroCutter 5/80™Dextera Surgical Receives Expanded Indication in Solid Organ Surgery for MicroCutter 5/80™
finance.yahoo.com - August 31 at 5:56 PM
3 Stocks To Watch Ahead Of Key Economic Results3 Stocks To Watch Ahead Of Key Economic Results
finance.yahoo.com - August 31 at 5:56 PM
Technical Snapshots for These Medical Supplies Stocks -- Dextera Surgical, DENTSPLY SIRONA, Baxter, and Mazor RoboticsTechnical Snapshots for These Medical Supplies Stocks -- Dextera Surgical, DENTSPLY SIRONA, Baxter, and Mazor Robotics
www.bizjournals.com - August 24 at 7:04 PM
Dextera Surgical to Present at Southern California Investor ConferenceDextera Surgical to Present at Southern California Investor Conference
finance.yahoo.com - August 21 at 5:45 PM
Dextera Surgical Inc. (DXTR) Earns Buy Rating from Analysts at Ladenburg Thalmann Financial ServicesDextera Surgical Inc. (DXTR) Earns Buy Rating from Analysts at Ladenburg Thalmann Financial Services
www.americanbankingnews.com - August 20 at 11:58 PM
Dextera Surgicals Automated Cardiac Anastomotic Devices to Be ... - Business Wire (press release)Dextera Surgical's Automated Cardiac Anastomotic Devices to Be ... - Business Wire (press release)
www.businesswire.com - August 18 at 12:17 AM
Dextera Surgical (DXTR) Presents At Wedbush PacGrow Healthcare Conference - SlideshowDextera Surgical (DXTR) Presents At Wedbush PacGrow Healthcare Conference - Slideshow
seekingalpha.com - August 17 at 7:16 PM
Dextera Surgical’s Automated Cardiac Anastomotic Devices to Be Featured at 2017 International Coronary CongressDextera Surgical’s Automated Cardiac Anastomotic Devices to Be Featured at 2017 International Coronary Congress
finance.yahoo.com - August 17 at 7:16 PM
-$0.06 Earnings Per Share Expected for Dextera Surgical Inc. (DXTR) This Quarter-$0.06 Earnings Per Share Expected for Dextera Surgical Inc. (DXTR) This Quarter
www.americanbankingnews.com - August 16 at 10:16 AM
Dextera Surgical to Present at 2017 Wedbush PacGrow Healthcare ConferenceDextera Surgical to Present at 2017 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 14 at 6:29 PM

SEC Filings

Dextera Surgical (NASDAQ:DXTR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Dextera Surgical (NASDAQ:DXTR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Dextera Surgical (NASDAQ DXTR) Stock Chart for Friday, December, 15, 2017

Loading chart…

This page was last updated on 12/15/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.